tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

LYRA Stock Latest News

Lyra Therapeutics Restructures Board of Directors
Company AnnouncementsLyra Therapeutics Restructures Board of Directors
8d ago
8K
LYRA
Lyra Therapeutics reports Q3 EPS (18c), consensus (23c)
PremiumThe Fly
Lyra Therapeutics reports Q3 EPS (18c), consensus (23c)
1M ago
LYRA
LYRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LYRA Upcoming Earnings Report: What to Expect?
2M ago
LYRA
Lyra Therapeutics fully enrolls Phase 3 ENLIGHTEN 2 trial of LYR-210
PremiumThe Fly
Lyra Therapeutics fully enrolls Phase 3 ENLIGHTEN 2 trial of LYR-210
2M ago
LYRA
Lyra Therapeutics reports Q2 EPS (74c), consensus (33c)
PremiumThe Fly
Lyra Therapeutics reports Q2 EPS (74c), consensus (33c)
4M ago
LYRA
Lyra Therapeutics trading resumes
PremiumThe FlyLyra Therapeutics trading resumes
7M ago
LYRA
Lyra implements layoff of 75% of workforce, to evaluate strategic options
Premium
The Fly
Lyra implements layoff of 75% of workforce, to evaluate strategic options
7M ago
LYRA
Lyra Therapeutics trading halted, news pending
Premium
The Fly
Lyra Therapeutics trading halted, news pending
7M ago
LYRA
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
8M ago
CVS
GLW
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target upgraded, CVS downgraded: Wall Street’s top analyst calls
8M ago
CVS
GLW
Lyra Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Lyra Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
8M ago
LYRA
Lyra Therapeutics downgraded to Underperform from Buy at BofA
PremiumThe Fly
Lyra Therapeutics downgraded to Underperform from Buy at BofA
8M ago
LYRA
Lyra Therapeutics downgraded to Hold from Buy at Jefferies
PremiumThe FlyLyra Therapeutics downgraded to Hold from Buy at Jefferies
8M ago
LYRA
Lyra Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
Lyra Therapeutics downgraded to Neutral from Buy at BTIG
8M ago
LYRA
Lyra Therapeutics downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Lyra Therapeutics downgraded to Market Perform from Outperform at William Blair
8M ago
LYRA
Lyra announces Phase 3 ENLIGHTEN 1 trial did not meet primary endpoint
PremiumThe Fly
Lyra announces Phase 3 ENLIGHTEN 1 trial did not meet primary endpoint
8M ago
LYRA
Lyra Therapeutics Navigates High-Stakes Clinical Trials Amid Safety and Efficacy Challenges
PremiumCompany Announcements
Lyra Therapeutics Navigates High-Stakes Clinical Trials Amid Safety and Efficacy Challenges
8M ago
LYRA
Lyra Therapeutics reports Q1 EPS (35c), consensus (26c)
PremiumThe Fly
Lyra Therapeutics reports Q1 EPS (35c), consensus (26c)
8M ago
LYRA
Lyra Therapeutics Announces Board and Committee Changes
PremiumCompany Announcements
Lyra Therapeutics Announces Board and Committee Changes
8M ago
8K
LYRA
Lyra Therapeutics management to meet with Cantor Fitzgerald
PremiumThe FlyLyra Therapeutics management to meet with Cantor Fitzgerald
8M ago
LYRA
Lyra Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Lyra Therapeutics management to meet with Cantor Fitzgerald
8M ago
LYRA
Lyra Therapeutics price target lowered to $11 from $12 at BofA
Premium
The Fly
Lyra Therapeutics price target lowered to $11 from $12 at BofA
9M ago
LYRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >